Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials

Erectile and Sexual Functions and Dysfunctions

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder

Obstet Gynecol.

Simon JA, Kingsberg SA, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Clayton AH

doi: 10.1097/AOG.0000000000003514.

Erectile and Sexual Functions and Dysfunctions

Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women

J Sex Med.

Pyke RE, Clayton AH

doi: 10.1016/j.jsxm.2019.09.005.

Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials

Lancet.

Meltzer-Brody S, Colquhoun H, Riesenberg R, Epperson CN, Deligiannidis KM, Rubinow DR, Li H, Sankoh AJ, Clemson C, Schacterle A, Jonas J, Kanes S

doi: 10.1016/S0140-6736

Erectile and Sexual Functions and Dysfunctions

Paroxetine, but not Vortioxetine, Impairs Sexual Functioning Compared With Placebo in Healthy Adults: A Randomized, Controlled Trial

J Sex Med.

Jacobsen P, Zhong W, Nomikos G, Clayton A

doi: 10.1016/j.jsxm.2019.06.018.

HPV and Gynecologic Cancer

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Lancet Oncol.

Vergote I, Scambia G, O'Malley DM, Van Calster B, Park SY, Del Campo JM, Meier W, Bamias A, Colombo N, Wenham RM, Covens A, Marth C, Raza Mirza M, Kroep JR, Ma H, Pickett CA, Monk BJ, TRINOVA-3/ENGOT-ov2/GOG-3001 investigators.

doi: 10.1016/S1470-2045(19)30178-0.

Erectile and Sexual Functions and DysfunctionsMenopause

Female Sexual Dysfunction: A Systematic Review of Outcomes Across Various Treatment Modalities

Sex Med Rev.

Weinberger JM, Houman J, Caron AT, Anger J

doi: 10.1016/j.sxmr.2017.12.004.

Uro-Oncology

Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial

Eur Urol

Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Schär C, Sumila M, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti DG, Khanfir K, Gomez S, Wust P, Thalmann GN, Aebersold DM, Swiss Group for Clinical Cancer Research (SAKK).

doi: 10.1016/j.eururo.2021.05.033

Erectile and Sexual Functions and DysfunctionsMenopause

Female Sexual Dysfunction and the Placebo Effect: A Meta-analysis

Obstet Gynecol.

Weinberger JM, Houman J, Caron AT, Patel DN, Baskin AS, Ackerman AL, Eilber KS, Anger JT

doi: 10.1097/AOG.

Urinary Incontinence

Three- and twelve-month follow-up outcomes of TVT-EXACT and TVT-ABBREVO for treatment of female stress urinary incontinence: a randomized clinical trial

World J Urol.

Feng S, Luo D, Liu Q, Yang T, Du C, Li H, Wang K, Shen H

doi: 10.1007/s00345-017-2165-7.

Related content

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder

Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women

Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials

Paroxetine, but not Vortioxetine, Impairs Sexual Functioning Compared With Placebo in Healthy Adults: A Randomized, Controlled Trial

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Female Sexual Dysfunction: A Systematic Review of Outcomes Across Various Treatment Modalities

Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial

Female Sexual Dysfunction and the Placebo Effect: A Meta-analysis

Three- and twelve-month follow-up outcomes of TVT-EXACT and TVT-ABBREVO for treatment of female stress urinary incontinence: a randomized clinical trial